REPORTS

Let’s Pullulate and Expand Your Business

Solid Organ Transplant Immunosuppressant Market - Global Professional Analysis and Forecast to 2026

Nov 30, 2019  |  223 PAGES  |  REPORT CODE: CMM255470
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Solid Organ Transplant Immunosuppressant market was valued at 2687.0 Million US$ in 2018 and is projected to reach 0.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.12% during the forecast period.

This report presents the market size and development trends by detailing the Solid Organ Transplant Immunosuppressant market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Solid Organ Transplant Immunosuppressant market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Solid Organ Transplant Immunosuppressant industry and will help you to build a panoramic view of the industrial development.

Solid Organ Transplant Immunosuppressant Market, By Type:

  • Antibodies

  • Antiproliferative Agents

  • Calcineurin Inhibitors

  • mTOR Inhibitors

  • Steroids

Solid Organ Transplant Immunosuppressant Market, By Application:

  • Bone Marrow Transplant

  • Heart Transplant

  • Kidney Transplant

  • Liver Transplant

  • Lung Transplant

  • Other Transplants

Some of the leading players are as follows:

  • Sanofi S.A.

  • Hoffmann-La Roche Ltd.

  • Janssen Pharmaceutical

  • Bristol-Myers Squibb Company

  • AbbVie, Inc.

  • Veloxis Pharmaceuticals

  • GlaxoSmithKline plc

  • Novartis AG

  • Allergan plc.

  • Pfizer, Inc.

  • Astellas Pharma, Inc.

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Solid Organ Transplant Immunosuppressant Market: Technology Type Analysis

  • 4.1 Solid Organ Transplant Immunosuppressant Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Solid Organ Transplant Immunosuppressant Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Antibodies

    • 4.3.2 Antiproliferative Agents

    • 4.3.3 Calcineurin Inhibitors

    • 4.3.4 mTOR Inhibitors

    • 4.3.5 Steroids

5 Solid Organ Transplant Immunosuppressant Market: Product Analysis

  • 5.1 Solid Organ Transplant Immunosuppressant Product Market Share Analysis, 2018 & 2026

  • 5.2 Solid Organ Transplant Immunosuppressant Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Solid Organ Transplant Immunosuppressant Market: Application Analysis

  • 6.1 Solid Organ Transplant Immunosuppressant Application Market Share Analysis, 2018 & 2026

  • 6.2 Solid Organ Transplant Immunosuppressant Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Bone Marrow Transplant

    • 6.3.2 Heart Transplant

    • 6.3.3 Kidney Transplant

    • 6.3.4 Liver Transplant

    • 6.3.5 Lung Transplant

    • 6.3.6 Other Transplants

7 Solid Organ Transplant Immunosuppressant Market: Regional Analysis

  • 7.1 Solid Organ Transplant Immunosuppressant Regional Market Share Analysis, 2018 & 2026

  • 7.2 Solid Organ Transplant Immunosuppressant Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Sanofi S.A.

    • 9.1.1 Sanofi S.A. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Hoffmann-La Roche Ltd.

    • 9.2.1 Hoffmann-La Roche Ltd. Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Janssen Pharmaceutical

    • 9.3.1 Janssen Pharmaceutical Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Bristol-Myers Squibb Company

    • 9.4.1 Bristol-Myers Squibb Company Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 AbbVie, Inc.

    • 9.5.1 AbbVie, Inc. Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Veloxis Pharmaceuticals

    • 9.6.1 Veloxis Pharmaceuticals Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 GlaxoSmithKline plc

    • 9.7.1 GlaxoSmithKline plc Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Novartis AG

    • 9.8.1 Novartis AG Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Allergan plc.

    • 9.9.1 Allergan plc. Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Pfizer, Inc.

    • 9.10.1 Pfizer, Inc. Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Astellas Pharma, Inc.

    • 9.11.1 Astellas Pharma, Inc. Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

 

The List of Tables and Figures (Totals 85 Figures and 134 Tables)

  • Figure Antibodies Solid Organ Transplant Immunosuppressant market, 2015 - 2026 (USD Million)

  • Figure Antiproliferative Agents Solid Organ Transplant Immunosuppressant market, 2015 - 2026 (USD Million)

  • Figure Calcineurin Inhibitors Solid Organ Transplant Immunosuppressant market, 2015 - 2026 (USD Million)

  • Figure mTOR Inhibitors Solid Organ Transplant Immunosuppressant market, 2015 - 2026 (USD Million)

  • Figure Steroids Solid Organ Transplant Immunosuppressant market, 2015 - 2026 (USD Million)

  • Figure Bone Marrow Transplant market, 2015 - 2026 (USD Million)

  • Figure Heart Transplant market, 2015 - 2026 (USD Million)

  • Figure Kidney Transplant market, 2015 - 2026 (USD Million)

  • Figure Liver Transplant market, 2015 - 2026 (USD Million)

  • Figure Lung Transplant market, 2015 - 2026 (USD Million)

  • Figure Other Transplants market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Solid Organ Transplant Immunosuppressant market, by country, 2015 - 2026 (USD Million)

  • Table North America Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table North America Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table North America Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table Canada Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table Canada Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Europe Solid Organ Transplant Immunosuppressant market, by country, 2015 - 2026 (USD Million)

  • Table Europe Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table Europe Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table Europe Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table Germany Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table Germany Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table France Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table France Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table Italy Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table Italy Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table Spain Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table Spain Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Solid Organ Transplant Immunosuppressant market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table China Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table China Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table Japan Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table Japan Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table India Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table India Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Solid Organ Transplant Immunosuppressant market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table MEA Solid Organ Transplant Immunosuppressant market, by country, 2015 - 2026 (USD Million)

  • Table MEA Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table MEA Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table MEA Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Solid Organ Transplant Immunosuppressant market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Solid Organ Transplant Immunosuppressant market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Solid Organ Transplant Immunosuppressant market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Sanofi S.A. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hoffmann-La Roche Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Janssen Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bristol-Myers Squibb Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AbbVie, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Veloxis Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline plc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Allergan plc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Astellas Pharma, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top